17-01-2022 08:00 via wallstreet-online.de

Angle PLC Announces Concordance of Parsortix with tissue biopsy

BREAKTHROUGH STUDY DEMONSTRATES FOR THE FIRST TIME CONCORDANCE OF PARSORTIX LIQUID BIOPSY BLOOD TEST WITH INVASIVE TISSUE BIOPSY OF THE METASTATIC SITEStudy explores key unmet medical need for metastatic breast cancer as over 50% of patients fail to …
Weiterlesen »